Synopsis of recent research by authors named "Sara Yankelev"
- Sara Yankelev's research primarily focuses on the safety and efficacy of daptomycin and other novel antibiotics in treating various Gram-positive and Gram-negative infections, particularly in surgical settings and prosthetic device-related infections.
- Recent studies include a phase II trial comparing ceftolozane-tazobactam combined with metronidazole to meropenem for complicated intra-abdominal infections, and a randomized controlled trial assessing the effectiveness of daptomycin versus standard therapy for osteomyelitis in patients undergoing revision arthroplasty.
- Her findings emphasize the potential of daptomycin in treating resistant infections and highlight the need for ongoing evaluation of antibiotic effectiveness against evolving resistant strains, notably in contexts like skin and soft tissue infections and enterococcal bacteremia.
